)
Visual24 Oct 2025
The rise of Alphabet
Enzymatica (ENZY) investor relations material
Enzymatica Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary30 Oct, 2025
Executive summary
Net sales for January–September 2025 increased 25.2% year-over-year to SEK 35.6 million, with Q3 sales up 19.4% to SEK 15.0 million compared to Q3 2024.
Operating loss for the nine-month period was SEK -41.1 million, compared to SEK -38.3 million last year; Q3 operating loss was SEK -8.2 million.
ColdZyme sales in Sweden grew 25.9% in Q3 and 27.1% for the nine-month period, outpacing the overall market.
New CEO Sana Alajmovic appointed, effective by January 2026; Claus Egstrand transitions to Board member.
Financial highlights
Gross margin for January–September was 62%, down from 68% year-over-year, impacted by higher manufacturing costs.
Earnings per share for January–September were SEK -0.17, an improvement from SEK -0.23 last year.
Cash flow from operating activities for the period was SEK -41.4 million, similar to SEK -40.0 million last year.
Net cash at period end was SEK 31.8 million, compared to net debt of SEK -1.7 million a year ago.
Available funds at period end totaled SEK 34.8 million.
Outlook and guidance
Financial targets remain: EBIT of at least SEK 170 million by end of 2027.
Focus remains on strengthening position in Sweden and expanding internationally through partnerships.
New net sales target to be communicated later.
What specific commercial terms are delaying partner deals?
Funding strategy given declining cash balance?
Long-term gross margin impact from packaging line costs?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Enzymatica earnings date
Q4 202518 Feb, 2026
Next Enzymatica earnings date
Q4 202518 Feb, 2026
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Enzymatica AB, a life science company, develops and sells medical devices for infection-related diseases in Sweden and internationally. The company offers ColdZyme, an oral spray for the treatment of common cold; and ear spray for the treatment of otitis media that is primarily intended for infants and small children. Its products are based on its patented enzyme technology, which mimics the body's natural system for managing harmful bacteria. The company markets its products to pharmacies, audiologists, cancer centers, leukemia patients, surgeons, and ENT departments; and online.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage